ING BlackRock Health Sciences Opp Adv (IEHAX)
* As of 28-Feb-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for IEHAX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.36%|
Performance & Risk
|5y Avg Return:||22.83%|
|Rank in Category (ytd):||55|
|% Rank in Category (ytd):||41.98%|
|Morningstar Risk Rating:||2|
The investment seeks long-term capital growth.
Under normal market conditions, the Portfolio invests at least 80% of its net assets (plus borrowings for investment purposes) in the equity securities, primarily common stocks, of companies in health sciences and related industries. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The Portfolio may invest in convertible securities, initial public offerings, and depositary receipts and may invest up to 15% of its net assets in illiquid/restricted securities. View More